These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 17361379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R, Kagna O, Israel O, Guralnik L.
    Cancer; 2008 Dec 01; 113(11):3213-21. PubMed ID: 18924145
    [Abstract] [Full Text] [Related]

  • 3. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y, Koyama H, Takenaka D, Nogami M, Maniwa Y, Nishimura Y, Ohbayashi C, Sugimura K.
    J Magn Reson Imaging; 2008 Jun 01; 27(6):1284-95. PubMed ID: 18504748
    [Abstract] [Full Text] [Related]

  • 4. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ, Lin SH, Lin KH, Lee CY, Chang CP, Wang SJ.
    Ann Nucl Med; 2008 Jul 01; 22(6):533-8. PubMed ID: 18670862
    [Abstract] [Full Text] [Related]

  • 5. Dynamic enhancement patterns of solitary pulmonary nodules at multi-detector row CT and correlation with vascular endothelial growth factor and microvessel density.
    Jiang NC, Han P, Zhou CK, Zheng JL, Shi HS, Xiao J.
    Ai Zheng; 2009 Feb 01; 28(2):164-9. PubMed ID: 19550130
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
    Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ.
    AJR Am J Roentgenol; 2006 Nov 01; 187(5):1361-7. PubMed ID: 17056930
    [Abstract] [Full Text] [Related]

  • 7. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
    Tian J, Yang X, Yu L, Chen P, Xin J, Ma L, Feng H, Tan Y, Zhao Z, Wu W.
    J Nucl Med; 2008 Feb 01; 49(2):186-94. PubMed ID: 18199618
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P, Perrone AM, Picchio M, Ghi T, Farsad M, Nanni C, Messa C, Meriggiola MC, Pelusi G, Al-Nahhas A, Rubello D, Fazio F, Fanti S.
    Nucl Med Commun; 2007 Aug 01; 28(8):589-95. PubMed ID: 17625380
    [Abstract] [Full Text] [Related]

  • 9. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
    Quaia E, Tona G, Gelain F, Lubin E, Pizzolato R, Boscolo E, Bussoli L.
    Acta Radiol; 2008 Nov 01; 49(9):995-1004. PubMed ID: 18651256
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of PET/CT in the characterization of solid or partly solid solitary pulmonary nodules.
    Jeong SY, Lee KS, Shin KM, Bae YA, Kim BT, Choe BK, Kim TS, Chung MJ.
    Lung Cancer; 2008 Aug 01; 61(2):186-94. PubMed ID: 18280613
    [Abstract] [Full Text] [Related]

  • 11. What is the clinical value of PET/CT in the diagnosis of pulmonary nodules?
    Lohrmann C, Weber WA.
    Zentralbl Chir; 2014 Feb 01; 139(1):108-13. PubMed ID: 24585199
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
    Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E, Ebied O.
    Eur J Radiol; 2009 Jun 01; 70(3):530-8. PubMed ID: 18395387
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
    Yamaguchi T, Ueda O, Hara H, Sakai H, Kida T, Suzuki K, Adachi S, Ishii K.
    Ann Nucl Med; 2009 Jan 01; 23(1):65-71. PubMed ID: 19205840
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K, Inubushi M, Wagatsuma K, Nagao M, Murata T, Koyama M, Koizumi M, Sasaki M.
    Eur J Radiol; 2014 Apr 01; 83(4):715-9. PubMed ID: 24418285
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
    Guo H, Zhu H, Xi Y, Zhang B, Li L, Huang Y, Zhang J, Fu Z, Yang G, Yuan S, Yu J.
    J Nucl Med; 2007 Aug 01; 48(8):1251-8. PubMed ID: 17631554
    [Abstract] [Full Text] [Related]

  • 19. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.
    J Nucl Med; 2009 Apr 01; 50(4):506-12. PubMed ID: 19289438
    [Abstract] [Full Text] [Related]

  • 20. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec 01; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.